Hopman Mark

Chief Commercial Officer

Hopman Mark has filed 9 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Hopman Mark is listed as Chief Commercial Officer at Beta Bionics, Inc. Inside the rolling window, Hopman Mark reported no open-market purchases and 10 open-market sales totaling $665K in BBNX. The largest disclosed transaction in the window is a sale of 11,411 BBNX shares on Sep 5, 2025, worth $235K.

Companies traded

Other insiders at BBNX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$665K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BBNXSale$102KSep 3SEC ↗
BBNXSale$19KJun 25SEC ↗
BBNXSale$3KJun 5SEC ↗
BBNXSale$67KJun 3SEC ↗
BBNXSale$25KMar 16SEC ↗
BBNXSale$63KMar 16SEC ↗
BBNXSale$4KMar 5SEC ↗
BBNXSale$10KMar 3SEC ↗
BBNXSale$136KSep 8SEC ↗
BBNXSale$235KSep 8SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Hopman Mark made?

Hopman Mark has filed 9 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.

Which companies does Hopman Mark trade?

Hopman Mark has filed SEC Form 4 disclosures for 1 company, including BBNX.

When was Hopman Mark's most recent SEC Form 4 filing?

Hopman Mark's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Hopman Mark's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hopman Mark is listed as Chief Commercial Officer.

What is Hopman Mark's total buy and sell value in the current window?

Inside the rolling retention window, Hopman Mark bought $0 and sold $665K based on SEC Form 4 filings.

What was Hopman Mark's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 11,411 BBNX shares on 2025-09-05, worth $235K, per SEC Form 4 filings.